General MedicationsINJECTIONGeneric
METHOTREXATE SODIUM
METHOTREXATE SODIUM
Standard Dose
EQ 20MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METHOTREXATE SODIUM is listed in Drugs@FDA under application 011719 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2025-05-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHOTREXATE SODIUM is listed in Drugs@FDA under application 011719 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2025-05-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.